• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A nomogram of preoperative predictors for occult metastasis in patients with PDAC during laparoscopic exploration.用于预测胰腺癌患者腹腔镜探查期间隐匿性转移的术前预测指标列线图。
Gland Surg. 2021 Jan;10(1):279-289. doi: 10.21037/gs-20-605.
2
Predictors of distant metastasis on exploration in patients with potentially resectable pancreatic cancer.可切除性胰腺癌患者术中远处转移的预测因素
BMC Gastroenterol. 2018 Nov 6;18(1):168. doi: 10.1186/s12876-018-0891-y.
3
Rim Enhancement and Peripancreatic Fat Stranding in Preoperative MDCT as Predictors for Occult Metastasis in PDAC Patients.术前 MDCT 中胰腺边缘强化和胰周脂肪条索征作为预测 PDAC 患者隐匿性转移的指标。
Acad Radiol. 2023 Dec;30(12):2954-2961. doi: 10.1016/j.acra.2023.03.007. Epub 2023 Apr 4.
4
Nomogram and competing risk model to predict recurrence after curative surgical resection of PDAC.预测胰腺癌根治性手术后复发的列线图和竞争风险模型。
Pancreatology. 2021 May 7. doi: 10.1016/j.pan.2021.04.010.
5
Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.伴有同步肝转移的胰腺导管腺癌的术前评估:不可切除性的诊断与评估
World J Gastroenterol. 2016 Dec 7;22(45):10024-10037. doi: 10.3748/wjg.v22.i45.10024.
6
Development and validation of a nomogram to predict liver metastasis for pancreatic ductal adenocarcinoma after radical resection.预测根治性切除术后胰腺导管腺癌肝转移的列线图的开发与验证
Front Oncol. 2022 Nov 21;12:1040411. doi: 10.3389/fonc.2022.1040411. eCollection 2022.
7
A Novel Nomogram to Predict Survival in Patients With Recurrence of Pancreatic Ductal Adenocarcinoma After Radical Resection.一种预测胰腺导管腺癌根治性切除术后复发患者生存情况的新型列线图。
Front Oncol. 2020 Sep 3;10:1564. doi: 10.3389/fonc.2020.01564. eCollection 2020.
8
Establishment and verification of prediction model of occult peritoneal metastasis in advanced gastric cancer.建立和验证晚期胃癌隐匿性腹膜转移的预测模型。
World J Surg Oncol. 2023 Oct 13;21(1):320. doi: 10.1186/s12957-023-03188-2.
9
Predictors of occult metastases in potentially Resectable pancreatic ductal adenocarcinoma.潜在可切除胰腺导管腺癌隐匿性转移的预测因素
Surg Open Sci. 2024 Jul 22;20:222-229. doi: 10.1016/j.sopen.2024.07.010. eCollection 2024 Aug.
10
Development and validation of a nomogram to predict liver metastasis in patients with pancreatic ductal adenocarcinoma: a large cohort study.预测胰腺导管腺癌患者肝转移的列线图的开发与验证:一项大型队列研究
Cancer Manag Res. 2019 May 2;11:3981-3991. doi: 10.2147/CMAR.S200684. eCollection 2019.

引用本文的文献

1
Preoperative MRI and CA19-9 for predicting occult lymph node metastasis in small pancreatic ductal adenocarcinoma (≤ 2 cm).术前MRI和CA19-9用于预测小胰腺癌(≤2cm)的隐匿性淋巴结转移。
BMC Med Imaging. 2025 Aug 6;25(1):318. doi: 10.1186/s12880-025-01854-3.
2
The Difficulty of Detecting Occult Metastases in Patients with Potentially Resectable Pancreatic Cancer: Development and External Validation of a Preoperative Prediction Model.检测潜在可切除胰腺癌患者隐匿性转移的难度:术前预测模型的开发与外部验证
J Clin Med. 2024 Mar 14;13(6):1679. doi: 10.3390/jcm13061679.
3
Development and validation of a deep learning radiomics model with clinical-radiological characteristics for the identification of occult peritoneal metastases in patients with pancreatic ductal adenocarcinoma.开发和验证一种基于深度学习的放射组学模型,结合临床-影像学特征,用于识别胰腺导管腺癌患者隐匿性腹膜转移。
Int J Surg. 2024 May 1;110(5):2669-2678. doi: 10.1097/JS9.0000000000001213.
4
Survival for Patients with Radiographically Occult Metastatic Pancreatic Cancer in the Era of Modern Multiagent Chemotherapy.现代多药化疗时代影像学隐匿性转移性胰腺癌患者的生存情况
Ann Surg Oncol. 2023 Jun;30(6):3194-3196. doi: 10.1245/s10434-023-13318-5. Epub 2023 Mar 14.

本文引用的文献

1
Assessment of Liver Metastases Using CT and MRI Scans in Patients with Pancreatic Ductal Adenocarcinoma: Effects of Observer Experience on Diagnostic Accuracy.使用CT和MRI扫描评估胰腺导管腺癌患者的肝转移:观察者经验对诊断准确性的影响。
Cancers (Basel). 2020 Jun 3;12(6):1455. doi: 10.3390/cancers12061455.
2
Elevated CEA and CA19-9 serum levels independently predict advanced pancreatic cancer at diagnosis.血清 CEA 和 CA19-9 水平升高可独立预测诊断时的晚期胰腺癌。
Biomarkers. 2020 Mar;25(2):186-193. doi: 10.1080/1354750X.2020.1725786. Epub 2020 Feb 13.
3
A prospective single-center protocol for using near-infrared fluorescence imaging with indocyanine green during staging laparoscopy to detect small metastasis from pancreatic cancer.一项前瞻性单中心研究方案,用于在分期腹腔镜检查期间使用吲哚菁绿近红外荧光成像检测胰腺癌微小转移灶。
BMC Surg. 2019 Nov 7;19(1):165. doi: 10.1186/s12893-019-0635-0.
4
Preoperative prediction of futile surgery in patients with radiologically resectable or borderline resectable pancreatic adenocarcinoma.影像学可切除或临界可切除胰腺腺癌患者无效手术的术前预测
J Gastroenterol Hepatol. 2020 Mar;35(3):499-507. doi: 10.1111/jgh.14837. Epub 2019 Sep 3.
5
The role of single-incision laparoscopic peritoneal exploration in the management of patients with peritoneal metastases.单孔腹腔镜腹膜探查术在腹膜转移患者治疗中的作用。
Surg Endosc. 2020 May;34(5):2040-2049. doi: 10.1007/s00464-019-06984-8. Epub 2019 Jul 18.
6
Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma.定义和预测 957 例接受胰腺导管腺癌切除患者的早期复发。
Ann Surg. 2019 Jun;269(6):1154-1162. doi: 10.1097/SLA.0000000000002734.
7
Opportunity Lost? Diagnostic Laparoscopy in Patients with Pancreatic Cancer in the National Surgical Quality Improvement Program Database.机会错失?美国国立外科手术质量改进计划数据库中胰腺癌患者的诊断性腹腔镜检查
World J Surg. 2019 Mar;43(3):937-943. doi: 10.1007/s00268-018-4855-8.
8
Pancreatic cancer: challenges and opportunities.胰腺癌:挑战与机遇。
BMC Med. 2018 Nov 22;16(1):214. doi: 10.1186/s12916-018-1215-3.
9
Predictors of distant metastasis on exploration in patients with potentially resectable pancreatic cancer.可切除性胰腺癌患者术中远处转移的预测因素
BMC Gastroenterol. 2018 Nov 6;18(1):168. doi: 10.1186/s12876-018-0891-y.
10
Incidence and risk factors for abdominal occult metastatic disease in patients with pancreatic adenocarcinoma.胰腺腺癌患者腹部隐匿性转移病的发生率及危险因素。
J Surg Oncol. 2018 Dec;118(8):1277-1284. doi: 10.1002/jso.25288. Epub 2018 Oct 31.

用于预测胰腺癌患者腹腔镜探查期间隐匿性转移的术前预测指标列线图。

A nomogram of preoperative predictors for occult metastasis in patients with PDAC during laparoscopic exploration.

作者信息

Ge Jiachen, Li Lei, Ma Zhaolai, Jiang Bin, Yuan Chunhui, Wang Hangyan, Peng Ying, Xiu Dianrong

机构信息

Department of General Surgery, Peking University Third Hospital, Beijing, China.

出版信息

Gland Surg. 2021 Jan;10(1):279-289. doi: 10.21037/gs-20-605.

DOI:10.21037/gs-20-605
PMID:33633984
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7882304/
Abstract

BACKGROUND

Surgical resection is the only potentially curative treatment for pancreatic ductal adenocarcinoma (PDAC). However, most of patients lose the chance of surgery due to the unresectable disease at the time of diagnosis. Despite the improvement of radiological imaging, a portion of patients intended for radical resection were proven to be unresectable at surgical exploration due to occult metastasis.

METHODS

Patients who were aimed to undergo radical pancreatectomy for PDAC from 2010 to 2019 were reviewed retrospectively. All patients included underwent diagnostic laparoscopic exploration. Patients were divided into two groups depending on whether distant metastasis were encountered during exploration. Univariate and multivariate logistic regression analyses were used to identify risk factors for occult metastasis. A nomogram to predict occult metastasis of PDAC on exploration was developed and evaluated.

RESULTS

A total of 273 patients who underwent diagnostic laparoscopic exploration were included in this study. Nineteen (7.0%) patients were found with distant metastasis during exploration. Multivariate logistic regression analysis showed that ALT>40U/L, CA19-9, CA125 and regional nodes enlargement were independent predictors for occult metastasis. Incorporating these four factors, the nomogram achieved concordance index of 0.799, with a well-fitted calibration curve.

CONCLUSIONS

Occult metastasis is not unusual during surgical exploration in patients with resectable or borderline resectable PDAC. The nomogram could achieve a personal prediction of unexpected distant metastasis on exploration. It may help to sift through patients with PDAC who would benefit from laparoscopic exploration.

摘要

背景

手术切除是胰腺导管腺癌(PDAC)唯一可能治愈的治疗方法。然而,大多数患者在诊断时因疾病无法切除而失去手术机会。尽管放射影像学有所改善,但一部分拟行根治性切除的患者在手术探查时因隐匿性转移而被证实无法切除。

方法

回顾性分析2010年至2019年旨在接受PDAC根治性胰腺切除术的患者。所有纳入患者均接受诊断性腹腔镜探查。根据探查时是否发现远处转移将患者分为两组。采用单因素和多因素逻辑回归分析确定隐匿性转移的危险因素。绘制并评估预测PDAC探查时隐匿性转移的列线图。

结果

本研究共纳入273例行诊断性腹腔镜探查的患者。19例(7.0%)患者在探查时发现远处转移。多因素逻辑回归分析显示,ALT>40U/L、CA19-9、CA125和区域淋巴结肿大是隐匿性转移的独立预测因素。纳入这四个因素后,列线图的一致性指数为0.799,校准曲线拟合良好。

结论

在可切除或临界可切除的PDAC患者手术探查期间,隐匿性转移并不少见。该列线图可对探查时意外的远处转移进行个体化预测。它可能有助于筛选出能从腹腔镜探查中获益的PDAC患者。